TOKYO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- MEDIROM MOTHER Labs Inc. (Headquarters: Minato-ku, Tokyo; President and CEO: Yoshio Uekusa; hereinafter “MOTHER Labs”), a subsidiary of MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM), today announced that it has approved a private placement of new shares to two officers, Yoshio Uekusa, President and CEO, and Ryo Saito, Director, as part of its Series A financing round, at a valuation of JPY9 billion. Funding is scheduled to occur by the end of October. ◼︎Backgrou ...

Core Viewpoint - MEDIROM Healthcare Technologies Inc. has announced the deployment of its remote health monitoring system "REMONY," utilizing the recharge-free smart tracker MOTHER Bracelet, to the Japan Ground Self-Defense Force (JGSDF) [2] Background of the Deployment - The need for effective health management and heatstroke prevention for personnel in extreme conditions has increased significantly [3] - Traditional wearable devices have limitations in remote areas with scarce power supply, making continuous health data collection challenging [4] Technology and Features - The MOTHER Bracelet employs thermoelectric generation technology, allowing uninterrupted operation without battery concerns, which was crucial for its adoption [5] - The device enables real-time health monitoring, helping to proactively identify risks such as heatstroke during extended missions [5] - The MOTHER Bracelet is the world's first 24/7 recharge-free smart tracker, utilizing temperature differences for power generation, thus preventing data loss during recharging [8] - It records five key metrics: heart rate, calories burned, body surface temperature, step count, and sleep [8] REMONY System Overview - REMONY combines the MOTHER Bracelet with a dedicated gateway for automatic data synchronization and centralized real-time management [11] - The system allows for continuous health monitoring without the need to remove the device for recharging, facilitating prompt detection of health emergencies [11] - It is customizable for various industries, including elderly care and health monitoring for night shift workers [11] Company Background - MEDIROM MOTHER Labs Inc., a subsidiary of MEDIROM Healthcare Technologies, focuses on health-tech solutions, including the development and sales of the MOTHER Bracelet [14]

Core Viewpoint - MEDIROM Healthcare Technologies Inc. has announced that its "REMONY for Driver" remote health management system has been certified by Japan's Ministry of Land, Infrastructure, Transport and Tourism as a device for preventing fatigue-related driving [2][4]. Group 1: Product Overview - "REMONY for Driver" utilizes the MOTHER Bracelet, a 24/7 wearable device that monitors drivers' health and alertness, featuring a proprietary sleep assessment function [3][11]. - The MOTHER Bracelet is the world's first recharge-free smart tracker, generating power from temperature differences, thus eliminating data loss during recharging [11][14]. - The system allows for real-time health monitoring and trend analysis, which can help prevent health-related accidents [3][14]. Group 2: Subsidy Program - The "REMONY for Driver" system is eligible for a subsidy covering 50% of the equipment acquisition cost, with a general cap of 800,000 yen per business operator [4][5]. - The Ministry of Land, Infrastructure, Transport and Tourism allocated approximately 1.3 billion yen in subsidies in the previous fiscal year, with a similar budget expected for the current fiscal year [4]. Group 3: Future Outlook - The company aims to enhance system functionality and promote safe driving practices, focusing on preventing fatigue-related driving in the transportation industry [8]. - Future initiatives include conducting safety check-in operations based on health data and improving driver health and workplace environments [7][8].

Core Points - MEDIROM Healthcare Technologies Inc. is participating in the "World" project, aimed at creating a digital infrastructure for "proof of humanness" in the AI era [2][3] - The company plans to install the World ID authentication device, "Orb," in approximately 100 Re.Ra.Ku relaxation salons, targeting access for up to 500,000 individuals [3][4] - Customers verifying their World ID can claim around 8,000 Japanese yen in Worldcoin tokens (WLD), which can be used to purchase gift certificates for Re.Ra.Ku salons [4] - Upon launching the program, the company intends to acquire WLD when customers purchase Re.Ra.Ku Tickets, with plans to exchange up to 50% of acquired WLD for Ethereum (ETH) [5] - The company aims to integrate next-generation digital infrastructure to create new value and achieve sustainable growth beyond traditional healthcare [6] Company Overview - MEDIROM operates over 300 relaxation salons in Japan under the "Re.Ra.Ku" brand, along with five other brands offering various health and wellness services [9] - The company provides health guidance and physical improvement programs through its healthcare app "Lav" and has expanded into device business with the "MOTHER Bracelet" [11] - Established in July 2000, MEDIROM is headquartered in Minato-ku, Tokyo, and is listed on NASDAQ under the ticker MRM [12]

Core Insights - MEDIROM Healthcare Technologies Inc. reported total revenue of $52,736,000 for the year ended December 31, 2024, representing a 22% increase from $43,388,000 in 2023 [1] - The net income for 2024 was $878,000, or $0.17 per basic share, a 20% improvement compared to $731,000, or $0.15 per basic share, in 2023 [1] Revenue Growth - The revenue growth in 2024 was primarily driven by a 23% increase in the Relaxation Salon Segment revenue, which reached $47,317,000 compared to $38,507,000 in 2023 [2] Cost Management - The increase in net income was attributed to a rise in total revenue, a decrease in the cost of revenues as a percentage of total revenues to 72.9% in 2024 from 77.0% in 2023, and a reduction in selling, general, and administrative expenses as a percentage of total revenues to 27.0% in 2024 from 28.7% in 2023 [3] Financial Position - As of December 31, 2024, MEDIROM had cash and cash equivalents of $2,093,000, up from $676,000 as of December 31, 2023 [4] - The total indebtedness increased to $11,925,000 in 2024 from $9,857,000 in 2023 [4] Cash Flow Analysis - Net cash used in operating activities was $8,462,000 in 2024, compared to $4,014,000 in 2023 [5] - Net cash provided in investing activities was $2,296,000 in 2024, while there was net cash used of $2,088,000 in 2023 [5] - Net cash provided by financing activities was $7,583,000 in 2024, an increase from $2,931,000 in 2023 [5] Strategic Developments - In 2025, MEDIROM announced the launch of its remote health monitoring system, REMONY, and the MOTHER Bracelet, targeting corporate clients [6] - The company aims to capture a significant share of the Japanese relaxation salon market and expand its Digital Preventative Healthcare business lines [6]

Core Insights - MEDIROM Healthcare Technologies Inc. announced a second investment by Yasuhiro Hayami, Chief Business Officer of MEDIROM Mother Labs Inc., in the Series A financing at a pre-money valuation of JPY9 billion (approximately US$60 million) [1] - This investment follows Mr. Hayami's initial investment in December 2024, indicating his commitment to the company's growth potential and alignment with MEDIROM's corporate philosophy [1] Company Overview - MEDIROM Mother Labs Inc. is a subsidiary of MEDIROM Healthcare Technologies Inc., focusing on the health-tech sector [6] - The company offers the "Specific Health Guidance Program" through the "Lav" health application and has developed the 24/7 recharge-free MOTHER Bracelet, which is a smart tracker [6][8] - The MOTHER Bracelet utilizes innovative technology to generate power based on temperature differences, allowing it to operate without recharging and recording key health metrics [8][9] Executive Background - Yasuhiro Hayami has a diverse career, including roles as Executive Officer at transcosmos inc. and founder of Wise, Inc., before becoming the Chief Business Officer of MEDIROM Mother Labs in 2024 [2][6]